Replies to post #6341 on Helix Technologies Inc. (fka HLIX)

[NobleRoman]

Thanks for breaking those out, Emerald!

Just to be clear, these are losses:

Security and guarding
Q1 EBITDA = -$726k
Q2 EBITDA = -$375k

Should be in () but, yes, I know what you mean. Numbers are accurate. I can't wait to dive in tomorrow when I have time.

Why don't you pose some questions. I appreciate you! Just, not about Form 4's, please. They answered. It's not a big deal. But you have a lot to contribute! And, everybody lies. Especially white lies. So, the logic doesn't necessarily follow that if you aren't straight on the small things then you'd be crooked on the big things. The whole Form 4 thing is just not professional. I have a question on it, but I don't particularly like it. That's why it's the last question on the list. ;)

But the software is definitely EBITDA positive. That's a good business. I liked the guard too. It was clearly still moving in the right direction. I did like the whole security suite offering. I don't know that $1.4M sounds like a whole lot for that... How do you feel about that price?

I'm not sure if that systems installation goes with it. I'm assuming it does. It sounds like it would be part of Helix Security.

So I have 2 questions I need to add later. Note to self:

1 about cannalytics contribution

2 about cash flows in Q2 broken out

Oh, and you know what else I like? It's never talked about. But I like having our own little software company Engini down there in South America somewhere. Our own internal IT dept. Upgrading Biotrac. And, they do outside sales as well. Not a big conribution to that, but it wasn't a big price tag. And, I just like it...

In hindsight, It seems to me Zac had a plan when he purchased it to be an integrator. They work as an internal consultant for merging techs too. I'm sure they played a big role in merging Amercanex and Cannalytics into Biotrack... And what is in store for them to do?

[NobleRoman]

Q2 Cash Flows, Emerald:

I'm not sure where they are pulling this from, Emerald:

Posted Q2 Cash Flows from Operations of $446k, a 162% improvement from Q2 2019

Do you know where that's coming from? They don't break it out in Q2, but that's what they are saying in their financial highlights of the PR today.

I'm not complaining. That's very good. Just as I said it would have to be in order to squeak out a small increase for the first 6 months. That's very good. That's undeniably cash flow positive from operations alone. Dilution, however, does dilute that. And it hurts. Toxic. Needs a strong anti-dillutive base. I see only one other big conversion coming up in September this year, which has potential to be sidestepped.


And then this is very encouraging:

"Exceeded 200 Cannalytics clients, more than doubling users in just one quarter"

I'm assuming that's revenue producing. They never actually say. It has to be very good margins when you already have the internal data, that's just growing with each market share grab. Cannabase's data in their too, I'm sure.

I hope they answer the question and break those numbers out. A doubling is really good. I'd like that to be an exponential trend.